Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04731129
Other study ID # 2018-192
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 15, 2020
Est. completion date November 30, 2023

Study information

Verified date March 2024
Source University of Liege
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Recently, probe based confocal laser endomicroscopy showed to be able to distinguish malignant from benign pleura during medical thoracoscopy. However The clinical usefulness of this new tool remains to be determined. The investigators believe that pCLE could be part of mini invasive pleural disease management and could be used during thoracentesis in order to increase the diagnostic yield of this procedure. The investigators are starting a prospective trial to recruit patients referred for medical thoracoscopy to the endoscopy unit. First, the pCLE probe will be introduced through the Boutin's needle or the thoracentesis catheter, just before the thoracoscopy, in order to investigate the pleural pCLE features and to identify or exclude malignant infiltration. Second those features will be compared to the pCLE acquisition obtained during the medical thoracoscopy (the probe is introduced through the working chanel of the thoracoscope), under visual control. In order to compare the invasive and mini invasive acquisition, 10 criteria will be prospectively assessed.Third, These features will be compared to the histological samples performed during thoracoscopy. Finally, the interpretation of different investigators will be compared. The 10 criteria are presented below: 1. Abnormal tissular architecture No: Correct identification of the previously described normal pleura characteristics Yes: identification of cellular/tissular structures which are not known to correspond to normal pleura (cellular clusters or dark clumps, glands, cells cordons, dysmorphic cells, papillar distribution….) 2. Cellular homogeneity is size, shape and fluorescence, as subjectively assessed by the investigator yes no 3. Mean cellular size: Small: < 10µm Moderate: 10 - 20µm Large: > 20µm 4. Cellular density (with reference to the Chia seed sign) Low (lower than the Chia seed sign) Moderate High 5. Dysplastic vessels: Yes: (vascular leaks, tortuous or giant vessels) No: no dysplasia 6. Vascular density (on a full optical area) Low: 0 -2 vessels Moderate: 3 - 4 vessels High: > 4 vessels 7. Organized or anarchic connective fibers Anarchic: coarse fibers, irregular in shape, without well-defined architecture Organized : regular in shape and direction, well defined architecture. 8. Chia seed sign on a full optical areal yes No


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date November 30, 2023
Est. primary completion date September 15, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Every patient referred to the endoscopy unit for medical thoracoscopy Exclusion Criteria: - Pregnancy - Known allergy to the fluorescein

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Probe based confocal laser endomicroscopy of the pleura
Every patient referred for medical thoracoscopy will be screened. The pCLE of the pleura will be performed 2 times. First, just before the thoracoscopy, through the Boutin's needle or the thoracentesis catheter and second through the working chanel of the pleuroscope. This last acquisition allows visual control to target the pleural endomicroscopy assessment. These two acquisitions will be compared between each other and with the histological samples of the pleuroscopy.

Locations

Country Name City State
Belgium Olivier Bonhomme Liege

Sponsors (1)

Lead Sponsor Collaborator
University of Liege

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity, specificity, positive predictive value and negative predictive value of mini invasive pleural pCLE assessment to identify malignant pleural infiltration. Before medical thoracoscopy, the pCLE probe will be introduced through the Boutin's needle or the thoracentesis catheter. The pleural pCLE acquisition will be assessed by two experienced and unblinded clinicians (aware of the medical history of the patient) during the procedure. A second acquisition and assessment of the criteria is performed thereafter during the medical thoracoscopy. 10 preselected criteria are used to assess the pCLE acquisition. They are the same than previously published (Bonhomme et al respirology 2020). A third blinded (not aware of the medical history of the patient) investigator will revise the pCLE acquisition (not the same day) to perform the same assessment. For the unblinded investigator: assessment of the videos is performed during the acquisition. For the blinded investigator, the assessment is performed within 30 days from the acquisition.
Secondary Reproducibility of the pCLE acquisition and assessment of the 10 preselected criteria between the mini invasive acquisition (during thoracentesis) and the invasive acquisition (during thoracoscopy) The pCLE features assessed during the mini invasive procedure will be compared to the assessment performed during the thoracoscopy. This assessment will be performed by the blinded investigator. The investigator will not know wether the pCLE acquisition is from mini invasive or invasive procedure for his assessment. The 10 criteria assessed during mini invasive or invasive pleural assessment will be compared to determine their reproducibility. The results will be presented for each criteria as the proportion of concordance between mini and invasive assessment. Within 30 days from the acquisition of the pCLE videos.
Secondary inter-observator reproducibility of the pCLE interpretation and assessment of the 10 criteria. The assessment of the 10 criteria will be compared between the different investigators in order to determine the reproducibility of the investigation. The results will be presented for each criteria as the proportion of concordance between mini and invasive assessment. Within 30 days from the acquisition of the pCLE videos
Secondary Safety of the mini invasive pleural pCLE assessment Every (Serious)adverse event will be reported during the intervention or during post intervention surveillance (1 hour post intervention). (Serious) adverse event will be recorded during the mini invasive and invasive assessment and until one hour post procedure.
See also
  Status Clinical Trial Phase
Recruiting NCT02891642 - Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Completed NCT03213834 - Fibrinolytic Therapy Versus Medical Thoracoscopy Phase 4
Recruiting NCT05910112 - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed NCT04538235 - Analgesic Non Inferiority of the Thoracic Bi-block in Comparison With Thoracic Epidural for VATS.
Completed NCT01475084 - Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study Phase 2/Phase 3
Completed NCT03468933 - Fibrinolysis Compared to Thoracoscopy for Pleural Infection Phase 4
Recruiting NCT03973957 - Talc Outpatient Pleurodesis With Indwelling Catheter N/A
Completed NCT03922841 - Pleural Disease: Phenotypes, Diagnostic Yield and Outcomes
Not yet recruiting NCT03172585 - Transthoracic Sonography Versus High Resolution Computed Tomography in Alveolar Intersitial Syndrome N/A
Not yet recruiting NCT06423066 - Developing a Machine Learning Model to Predict Pleural Adhesion Preoperatively Using Pleural Ultrasound
Completed NCT02973139 - Fibrinolysis Compared to Thoracoscopy for Pleural Infection N/A
Completed NCT03997669 - The Diagnosis and Mechanism of Pleural Effusion
Completed NCT02359383 - Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion N/A
Completed NCT01366261 - Rigid Versus Semirigid Thoracoscopy in Diagnosing Pleural Diseases: a Randomized Study Phase 3
Completed NCT00720954 - Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy N/A
Completed NCT01193439 - Safety of Thoracoscopy in Patients With High Risk N/A
Recruiting NCT04193241 - Suturing With U-Technique Versus Un-Reapproximated Wound Edges During Removal of Closed Thoracostomy Tube Drain N/A
Recruiting NCT06180603 - Strategy for Prompt and Effective Thoracentesis in the Emergency Department N/A
Recruiting NCT06226909 - The Efficacy of Shear-wave Elastography-guided Biopsy for Diagnosis in Pleural Disease N/A
Active, not recruiting NCT05077111 - A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia Phase 4